Advanced search
Publication Cover
Acta Cardiologica Volume 59, 2004 - Issue 1
Submit an article Journal homepage
5
Views
2
CrossRef citations to date
0
Altmetric
Articles

Left ventricular thrombosis is associated with increased mean platelet volume in patients with dilated cardiomyopathy and sinus rhythm

Mehmet Birhan YilmazYuksek Ihtisas Hospital, Cardiology Clinic, Sihhiye, Ankara, TurkeyCorrespondence[email protected]
,
Yesim AkinYuksek Ihtisas Hospital, Cardiology Clinic, Sihhiye, Ankara, Turkey
,
Senay Funda BiyikogluYuksek Ihtisas Hospital, Cardiology Clinic, Sihhiye, Ankara, Turkey
,
Umit GurayYuksek Ihtisas Hospital, Cardiology Clinic, Sihhiye, Ankara, Turkey
,
Halil L. KisacikYuksek Ihtisas Hospital, Cardiology Clinic, Sihhiye, Ankara, Turkey
&
Sule KorkmazYuksek Ihtisas Hospital, Cardiology Clinic, Sihhiye, Ankara, Turkey
Pages 41-45 | Received 28 Jan 2003, Accepted 23 Jun 2003, Published online: 23 May 2017

References

  • The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325(5): 293–302.
  • Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Fran-cis GS, Flohr KH, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314(24): 1547–52.
  • Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voorhees L, Gourley LA, Jolly MK. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. N Engl J Med 1993; 329(1): 1–7.
  • Rousseau MF, Gurne 0, Duprez D, Van Mieghem W, Robert A, Ahn S, Galanti L, Ketelslegers JM. Beneficial neurohormonal profile of spironolactone in severe conges-tive heart failure: results from the RALES neurohormonal substudy. J Am Coll Cardiol 2002; 40(9): 1596–601.
  • Hermann DD. Beta-adrenergic blockade 2002: a pharma-cologic odyssey in chronic heart failure. Congest Heart Fail 2002; 8(5): 262–9; 283 (review).
  • Knaus WA, Harrell FE Jr, Lynn J, Goldman L, Phillips RS, Connors AF Jr, Dawson NV, Fulkerson WJ Jr, Calif RM, Desbiens N, et al. The SUPPORT prognostic model. Objec-tive estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments Ann Intern Med 1995; 122(3): 191–203.
  • Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med 1999; 341(8): 577–85.
  • Jafri SM, Ozawa T, Mammen E, Levine TB, Johnson C, Goldstein S. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J 1993; 14(2): 205–12.
  • Mehta J, Mehta P. Platelet function studies in heart disease. VI. Enhanced platelet aggregate formation activity in con-gestive heart failure: inhibition by sodium nitroprusside. Cir-culation 1979; 60(3): 497–503.
  • Sbarouni E, Bradshaw A, Andreotti F, Tuddenham E, Oakley CM, Cleland JG. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J1994; 127(3): 607–12.
  • Jafri SM, Mammen EF, Masura J, Goldstein S. Effects of warfarin on markers of hypercoagulability in patients with heart failure. Am Heart J1997; 134(1): 27–36.
  • The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992; 116(1): 6–12.
  • Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW et al. ACC/AHA guidelines for the evaluation and manage-ment of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Associa-tion Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the Inter-national Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circula-tion 2001; 104(24): 2996–3007.
  • Karpatkin S. Heterogeneity of human platelets. VI. Corre-lation of platelet function with platelet volume. Blood 1978; 51: 307–16.
  • Karpatkin S. Heterogeneity of human platelets. II. Func-tional evidence suggestive of young and old platelets. J Clin Invest 1969; 48: 1083–7.
  • Paulus JM. Platelet size in man. Blood 1975; 46: 321–36.
  • Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size and age determine platelet function independently. Blood 1984; 63: 1372–5.
  • Martin JF, Penington DG. The relationship between the age and density of circulating 51-Cr labelled platelets in the sub-human primate. Thromb Res 1983; 30: 157–64.
  • Tong M, Seth P, Penington DG. Proplatelets and stress platelets. Blood 1987; 69: 522–8.
  • Martin JF. Platelet heterogeneity in vascular disease. In: Martin JF, Trowbridge EA, eds. Platelet heterogeneity: biol-ogy and pathology. London: Springer-Verlag; 1990: 205–26.
  • Karpatkin S. Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest 1969; 48: 1073–82.
  • Corash L, Tau H, Gralnick HR. Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood 1977; 49: 71–87.
  • Thompson CB, Monroy RL, Skelly RR, Quinn PG, Jakubowski A. The biology of platelet volume heterogeneity. In: Martin JF, Trowbridge EA, eds. Platelet heterogeneity: biology and pathology. London: Springer-Verlag; 1990:25–35.
  • Heptinstall S, Mulley GP, Taylor PM, Mitchell JRA. Platelet release reaction in myocardial infarction. BMJ 1980; 280: 80–1.
  • Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409–11.
  • Hirsh J, Anand SS, Halperin JL, Fuster V. Guide to anti-coagulant therapy: heparin: a statement for healthcare pro-fessionals from the American Heart Association. Circula-tion 2001; 103(24): 2994–3018 (review).
  • Cleland JG, John J, Dhawan J, Clark A. What is the opti-mal medical management of ischaemic heart failure? Br Med Bull 2001; 59: 135–58.
  • Herbert JM, Bernat A, Maffrand JP. Importance of platelets in experimental venous thrombosis in the rat. Blood 1992; 80(9): 2281–6.
  • Helenski CA, Ross JN Jr. Platelet aggregation in feline car-diomyopathy. J Vet Intern Med 1987; 1(1): 24–8.
  • Han XM, Chen ZQ, Mao HM. Simultaneous detection of the platelet aggregation and release in patients with cardio-cerebral vascular diseases associated with blood stasis and their clinical significance. Zhong Xi Yi Jie He Za Zhi 1991; 11(6): 334–6. (abstract in Chinese).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.